Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - clomipramine hydrochloride - oral capsule - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - clomipramine hydrochloride - oral capsule - 10mg

Bandaríkin - enska - NLM (National Library of Medicine)

mizner bioscience, llc - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomipramine hydrochloride tablets are to be used as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age. inappropriate barking or destructive behavior, as well as inappropriate elimination (urination or defecation) may be alleviated by the use of clomipramine hydrochloride tablets in conjunction with behavior modification. separation anxiety is a complex behavior disorder displayed when the owner (or other attachment figure) leaves the dog. the signs of separation anxiety evaluated in controlled trials were vocalization, destructive behavior, excessive salivation, and inappropriate elimination. in the absence of the owner or attachment figure, dogs with separation anxiety may exhibit one or more of these clinical signs. although the owner (attachment figure) may inadvertently misinterpret this behavior, which only happens in their absence, as spiteful, it is thought to be the result of anxiety experienced by the dog. punishment is not conside

Bandaríkin - enska - NLM (National Library of Medicine)

covetrus north america - clomipramine hydrochloride (unii: 2lxw0l6gwj) (clomipramine - unii:nuv44l116d) - clomipramine hydrochloride tablets are to be used as part of a comprehensive behavioral management program to treat separation anxiety in dogs greater than 6 months of age. inappropriate barking or destructive behavior, as well as inappropriate elimination (urination or defecation) may be alleviated by the use of clomipramine hydrochloride tablets in conjunction with behavior modification. separation anxiety is a complex behavior disorder displayed when the owner (or other attachment figure) leaves the dog. the signs of separation anxiety evaluated in controlled trials were vocalization, destructive behavior, excessive salivation, and inappropriate elimination. in the absence of the owner or attachment figure, dogs with separation anxiety may exhibit one or more of these clinical signs. although the owner (attachment figure) may inadvertently misinterpret this behavior, which only happens in their absence, as spiteful, it is thought to be the result of anxiety experienced by the dog. punishment is not conside